Home » Stocks » Achieve Life Sciences

Achieve Life Sciences, Inc. (ACHV)

Stock Price: $8.75 USD 0.30 (3.55%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 31.39M
Revenue (ttm) n/a
Net Income (ttm) -13.11M
Shares Out 3.59M
EPS (ttm) -12.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $8.75
Previous Close $8.45
Change ($) 0.30
Change (%) 3.55%
Day's Open 8.43
Day's Range 8.40 - 9.13
Day's Volume 55,563
52-Week Range 4.51 - 30.40

More Stats

Market Cap 31.39M
Enterprise Value 19.50M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 3.59M
Float 3.57M
EPS (basic) -16.68
EPS (diluted) -12.35
FCF / Share -7.55
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 563,910
Short Ratio 2.06
Short % of Float 15.80%
Beta 1.42
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.20
Revenue n/a
Operating Income -13.20M
Net Income -13.11M
Free Cash Flow -13.16M
Net Cash 11.89M
Net Cash / Share 3.31
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -52.87%
ROE -100.68%
ROIC 1,636.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$43.00*
(391.43% upside)
Low
21.0
Current: $8.75
High
100.0
Target: 43.00
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue----18.1627.1229.8820.105.5013.62
Revenue Growth-----33.03%-9.26%48.7%265.63%-59.64%-
Gross Profit----18.1627.1229.8820.105.5013.62
Operating Income-16.53-12.81-6.63-1.71-18.75-29.47-35.33-25.99-22.29-14.75
Net Income-16.40-12.69-10.58-1.23-16.80-26.24-31.85-21.10-14.67-12.58
Shares Outstanding0.410.180.02-0.010.010.010.01--
Earnings Per Share-39.80-72.20-441.40-11,625.00-1,407.99-3,189.97-4,773.95-3,431.97-3,321.97-3,937.96
Operating Cash Flow-15.22-10.62-9.11-0.20-9.10-17.31-35.93-43.49-20.26-26.84
Capital Expenditures-0.05-0.04---0.37-0.08-0.25-0.29-0.08-0.07
Free Cash Flow-15.27-10.66-9.11-0.20-9.47-17.39-36.18-43.78-20.34-26.91
Cash & Equivalents16.7114.655.560.0255.4647.3139.5475.7065.3085.61
Total Debt0.360.020.030.830.160.254.645.347.768.01
Net Cash / Debt16.3514.635.53-0.8155.3047.0634.9070.3657.5577.60
Assets21.0819.089.893.8158.2156.2955.6982.0268.0289.92
Liabilities3.033.282.013.2020.7722.2318.4815.8137.1345.79
Book Value18.0515.807.880.6137.4434.0637.2166.2130.8944.13
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Achieve Life Sciences, Inc.
Country Canada
Employees 14
CEO John A. Bencich

Stock Information

Ticker Symbol ACHV
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ACHV

Description

Achieve Life Sciences, a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.